Arca
Skip to content

CranioXpand

Cranial Distraction System. 510(k) K230211, from KLS-Martin L.P. (Jacksonville, FL). Product code PBJ, class 2.

As of Nov 17, 2026, K230211 is an FDA 510(k) held by KLS-Martin L.P., substantially equivalent on Nov 21, 2023 after 299 days, with no recalls tied to it in FDA's recall database.

  • Substantially equivalent: Nov 21, 2023
  • Review time: 299 days
  • Recalls: 0

Indications for Use

As the 510(k) summary states them, read from FDA's summary PDF

The KLS Martin CranioXpand Spring system is indicated for use in the treatment of cranial conditions such as craniosynostosis and congenital deficiencies in which osteotomies and gradual bone distraction are indicated for the infant pediatric subpopulation (29 days to < 2 years of age).

Predicate Devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Record

Type
Traditional
Received
Jan 26, 2023
Review panel
Neurology
Regulation
21 CFR 882.5330

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.